These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19966175

  • 1. Trimetazidine shortens QTc interval in patients with ischemic heart failure.
    Zemljic G, Bunc M, Vrtovec B.
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):31-6. PubMed ID: 19966175
    [Abstract] [Full Text] [Related]

  • 2. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):24-30. PubMed ID: 20100903
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 4. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 05; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 5. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK.
    Klin Med (Mosk); 2004 Nov 05; 82(11):15-20. PubMed ID: 15656392
    [Abstract] [Full Text] [Related]

  • 6. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 05; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 7. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 05; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 05; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 9. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 10. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.
    Heart; 2011 Sep 28; 97(18):1495-500. PubMed ID: 21700755
    [Abstract] [Full Text] [Related]

  • 11. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 28; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 12. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 28; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 13. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus.
    Vrtovec M, Vrtovec B, Briski A, Kocijancic A, Anderson RA, Radovancevic B.
    Am Heart J; 2005 Apr 28; 149(4):632-6. PubMed ID: 15990745
    [Abstract] [Full Text] [Related]

  • 14. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 28; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 15. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Radovancevic B.
    J Card Fail; 2005 Dec 28; 11(9):684-90. PubMed ID: 16360963
    [Abstract] [Full Text] [Related]

  • 16. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS, Torgomian AL, Barkhudarian AL.
    Klin Med (Mosk); 2006 Dec 28; 84(10):55-8. PubMed ID: 17201276
    [Abstract] [Full Text] [Related]

  • 17. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V, Bouzas-Mosquera A, Kaski JC.
    Am J Cardiol; 2006 Sep 04; 98(5A):19J-24J. PubMed ID: 16931202
    [Abstract] [Full Text] [Related]

  • 18. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
    Corović N, Duraković Z, Misigoj-Duraković M.
    Alcohol Clin Exp Res; 2006 Jan 04; 30(1):150-4. PubMed ID: 16433743
    [Abstract] [Full Text] [Related]

  • 19. Effect of medical therapy on left ventricular ejection fraction in patients with systolic heart failure and narrow QRS duration with and without ischemic heart disease and left ventricular mechanical dyssynchrony.
    Nair CK, Shen X, Aronow WS, Li H, Holmberg MJ, Korlakunta H, Hee T, Maciejewski S, Esterbrooks DJ.
    Am J Ther; 2010 Jan 04; 17(1):e1-7. PubMed ID: 19262361
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.
    Kolo PM, Opadijo OG, Omotoso AB, Balogun MO, Araoye MA, Katibi IA.
    West Afr J Med; 2008 Apr 04; 27(2):69-73. PubMed ID: 19025017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.